RAPID MICRO BIOSYSTEMS, INC.
Unaudited Condensed Consolidated Statements of Operations
(in thousands, except share and per share amounts)
       
  Three Months Ended September 30,   Nine Months Ended September 30,
  2024   2023   2024   2023
Revenue:              
Product revenue $ 5,255     $ 4,200     $ 13,505     $ 10,693  
Service revenue   2,349       1,945       6,328       5,489  
Total revenue   7,604       6,145       19,833       16,182  
Costs and operating expenses:              
Cost of product revenue   5,314       5,691       15,404       15,361  
Cost of service revenue   1,668       2,085       5,519       6,134  
Research and development   3,609       3,116       11,195       9,502  
Sales and marketing   3,376       3,498       10,284       10,161  
General and administrative   5,676       6,204       17,121       19,399  
Total costs and operating expenses   19,643       20,594       59,523       60,557  
Loss from operations   (12,039 )     (14,449 )     (39,690 )     (44,375 )
Other income (expense):              
Interest income, net   768       1,093       2,589       3,169  
Other expense, net   (39 )     (26 )     (91 )     (66 )
Total other income, net   729       1,067       2,498       3,103  
Loss before income taxes   (11,310 )     (13,382 )     (37,192 )     (41,272 )
Income tax expense   13       10       31       23  
Net loss $ (11,323 )   $ (13,392 )   $ (37,223 )   $ (41,295 )
Net loss per share — basic and diluted $ (0.26 )   $ (0.31 )   $ (0.86 )   $ (0.96 )
Weighted average common shares outstanding — basic and diluted   43,668,656       43,080,095       43,510,911       42,985,184  
                               

 

RAPID MICRO BIOSYSTEMS, INC.
Unaudited Condensed Consolidated Balance Sheets
(in thousands)
 
  September 30, 
2024		   December 31, 
2023
Assets      
Current assets:      
Cash and cash equivalents $ 22,044   $ 24,285
Short-term investments   38,788     67,768
Accounts receivable   3,740     5,532
Inventory   21,253     19,961
Prepaid expenses and other current assets   2,109     2,869
Total current assets   87,934     120,415
Property and equipment, net   11,563     12,832
Right-of-use assets, net   5,420     6,240
Long-term investments   —     2,911
Other long-term assets   642     770
Restricted cash   284     284
Total assets $ 105,843   $ 143,452
Liabilities and Stockholders’ Equity      
Current liabilities:      
Accounts payable $ 2,329   $ 1,973
Accrued expenses and other current liabilities   7,038     9,907
Deferred revenue   5,360     5,974
Lease liabilities, short-term   1,193     1,132
Total current liabilities   15,920     18,986
Lease liabilities, long-term   5,261     6,214
Other long-term liabilities   289     263
Total liabilities   21,470     25,463
Total stockholders’ equity   84,373     117,989
Total liabilities and stockholders’ equity $ 105,843   $ 143,452
           

 

RAPID MICRO BIOSYSTEMS, INC.
Unaudited Cash, Cash Equivalents and Investments
(in thousands)
 
  September 30,
2024		   December 31,
2023
Cash and cash equivalents $ 22,044   $ 24,285
Short-term investments   38,788     67,768
Long-term investments   —     2,911
Cash, cash equivalents and investments $ 60,832   $ 94,964